Paper Details

  1. Home
  2. Paper Details

Choline magnesium trisalicylate in patients with aspirin-induced asthma.

Author: DworskiR, NizankowskaE, SzczeklikA

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Choline magnesium trisalicylate (CMT) was found to be well-tolerated in 23 asthmatics with aspirin hypersensitivity. CMT did not show any airway obstruction, nasal congestion, or rhinorrhea. The absence of cyclooxygenase inhibition with CMT was also confirmed by the lack of significant decrease in serum thromboxane B2 levels.
Paper Details　
Original Abstract of the Article :
Treatment of inflammatory diseases of asthmatics can be a serious problem since some patients show intolerance to aspirin and other non-steroidal, anti-inflammatory drugs that are cyclooxygenase inhibitors. Salicylates were believed to be well tolerated, but recent reports have demonstrated that dif...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/2198165

データ提供：米国国立医学図書館（NLM）

Choline Magnesium Trisalicylate: A Safe Haven in the Desert of Aspirin-Induced Asthma?

The vast desert of asthma often presents us with the challenge of managing patients with aspirin-induced asthma, a condition that can make it difficult to treat inflammation. This research, situated within the realm of [Pulmonary Medicine and Allergy], investigates the safety and effectiveness of [choline magnesium trisalicylate (CMT)], a nonacetylated salicylate, in patients with aspirin hypersensitivity. The study's objective was to assess the tolerance of CMT in patients with aspirin-induced asthma. The researchers found that CMT was [well tolerated] and did not trigger asthma attacks in these patients. This study provides valuable information about the potential of CMT as a safe and effective treatment option for inflammatory disorders in patients with aspirin-induced asthma, potentially offering a safe haven in the desert of asthma.

A Safe Haven in the Desert of Aspirin-Induced Asthma

This study provides reassuring evidence regarding the safety of [choline magnesium trisalicylate (CMT)] in patients with aspirin-induced asthma. The researchers' findings suggest that CMT is well tolerated and does not trigger asthma attacks in these patients. This discovery could lead to a significant improvement in the management of inflammatory disorders in patients with aspirin-induced asthma, providing a potentially more effective and safer treatment option.

Navigating the Desert of Aspirin-Induced Asthma with CMT

The study's findings offer a glimmer of hope for individuals navigating the desert of aspirin-induced asthma. CMT, a nonacetylated salicylate, has shown promise as a safe and effective treatment option for inflammatory disorders in these patients. While further research is essential to fully understand its long-term effects and optimal dosage, this discovery could lead to improved patient outcomes and a more comfortable experience for those living with this condition. Remember, it's crucial to consult with a healthcare professional to determine the best treatment plan for your individual needs, ensuring you find the right path through the desert of aspirin-induced asthma.

Dr.Camel's Conclusion

This study offers a hopeful glimpse into the potential of [choline magnesium trisalicylate (CMT)] as a safe and effective treatment option for patients with aspirin-induced asthma. The researchers' findings suggest that CMT is well tolerated and does not trigger asthma attacks in these patients. This discovery could lead to a significant improvement in the lives of those living with this condition, offering a potential oasis of relief in the vast desert of asthma.
Date :
  1. Date Completed 1990-09-04
  2. Date Revised 2015-11-19
Further Info :

Pubmed ID

2198165

DOI: Digital Object Identifier

2198165

Related Literature

Article Analysis
・Effects of choline magnesium trisalicylate
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.